The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
297.20
-0.70 (-0.23%)
At close: Nov 4, 2026
DSE:IBNSINA Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 9,286 | 9,985 | 9,189 | 7,805 | 8,954 | 9,270 | |
Market Cap Growth | 1.33% | 8.67% | 17.73% | -12.84% | -3.40% | 20.27% |
Enterprise Value | 13,134 | 13,273 | 10,667 | 8,919 | 9,692 | 9,892 |
Last Close Price | 297.20 | 311.41 | 280.42 | 233.31 | 262.07 | 266.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 11.69 | 12.57 | 14.51 | 11.64 | 14.79 | 15.30 |
Forward PE | - | 12.71 | 12.73 | 10.24 | 12.68 | - |
PS Ratio | 0.67 | 0.72 | 0.77 | 0.69 | 0.98 | 1.09 |
PB Ratio | 1.99 | 2.15 | 2.30 | 2.21 | 2.93 | 3.53 |
P/TBV Ratio | 2.06 | 2.21 | 2.34 | 2.23 | 2.96 | 3.56 |
P/FCF Ratio | - | - | - | - | 18.93 | 173.59 |
P/OCF Ratio | 7.83 | 8.42 | 12.70 | 20.02 | 9.97 | 22.15 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.94 | 0.96 | 0.90 | 0.78 | 1.06 | 1.17 |
EV/EBITDA Ratio | 10.02 | 10.12 | 9.81 | 8.16 | 6.22 | 9.69 |
EV/EBIT Ratio | 11.86 | 11.99 | 11.82 | 9.75 | 11.82 | 12.05 |
EV/FCF Ratio | - | - | - | - | 20.49 | 185.25 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.86 | 0.86 | 0.52 | 0.53 | 0.32 | 0.41 |
Debt / EBITDA Ratio | 3.06 | 3.06 | 1.86 | 1.69 | 0.62 | 1.02 |
Debt / FCF Ratio | - | - | - | - | 2.09 | 20.02 |
Net Debt / Equity Ratio | 0.80 | 0.80 | 0.43 | 0.38 | 0.24 | 0.27 |
Net Debt / EBITDA Ratio | 2.83 | 2.83 | 1.58 | 1.22 | 0.47 | 0.68 |
Net Debt / FCF Ratio | -2.01 | -2.01 | -6.66 | -2.39 | 1.53 | 13.03 |
Asset Turnover | 1.51 | 1.51 | 1.69 | 1.98 | 1.96 | 2.08 |
Inventory Turnover | 4.31 | 4.31 | 4.18 | 4.99 | 4.86 | 5.49 |
Quick Ratio | 0.10 | 0.10 | 0.22 | 0.32 | 0.23 | 0.35 |
Current Ratio | 0.68 | 0.68 | 1.15 | 1.13 | 1.26 | 1.46 |
Return on Equity (ROE) | 18.33% | 18.33% | 16.82% | 20.38% | 21.33% | 25.37% |
Return on Assets (ROA) | 7.54% | 7.54% | 8.02% | 9.93% | 11.00% | 12.59% |
Return on Invested Capital (ROIC) | 10.81% | 12.28% | 12.81% | 15.78% | 17.23% | 20.43% |
Return on Capital Employed (ROCE) | 18.60% | 18.60% | 17.80% | 21.80% | 23.10% | 25.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 8.56% | 7.96% | 6.89% | 8.59% | 6.76% | 6.54% |
FCF Yield | -19.90% | -18.50% | -2.81% | -7.13% | 5.28% | 0.58% |
Dividend Yield | 2.59% | - | 2.18% | 2.52% | 2.09% | 2.02% |
Payout Ratio | 26.93% | 26.93% | 30.62% | 26.83% | 29.49% | 29.28% |
Total Shareholder Return | 2.59% | - | 2.18% | 2.52% | 2.09% | 2.02% |